376 related articles for article (PubMed ID: 21720932)
21. Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls.
Jakimovski D; Bergsland N; Dwyer MG; Hagemeier J; Ramasamy DP; Szigeti K; Guttuso T; Lichter D; Hojnacki D; Weinstock-Guttman B; Benedict RHB; Zivadinov R
Neurobiol Aging; 2020 Jun; 90():84-92. PubMed ID: 32147244
[TBL] [Abstract][Full Text] [Related]
22. Shape changes of the basal ganglia and thalamus in Alzheimer's disease: a three-year longitudinal study.
Cho H; Kim JH; Kim C; Ye BS; Kim HJ; Yoon CW; Noh Y; Kim GH; Kim YJ; Kim JH; Kim CH; Kang SJ; Chin J; Kim ST; Lee KH; Na DL; Seong JK; Seo SW
J Alzheimers Dis; 2014; 40(2):285-95. PubMed ID: 24413620
[TBL] [Abstract][Full Text] [Related]
23. Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set.
Marzi C; d'Ambrosio A; Diciotti S; Bisecco A; Altieri M; Filippi M; Rocca MA; Storelli L; Pantano P; Tommasin S; Cortese R; De Stefano N; Tedeschi G; Gallo A;
Hum Brain Mapp; 2023 Jan; 44(1):186-202. PubMed ID: 36255155
[TBL] [Abstract][Full Text] [Related]
24. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
[TBL] [Abstract][Full Text] [Related]
25. The impact of deep grey matter volume on cognition in multiple sclerosis.
Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
[TBL] [Abstract][Full Text] [Related]
26. More atrophy of deep gray matter structures in frontotemporal dementia compared to Alzheimer's disease.
Möller C; Dieleman N; van der Flier WM; Versteeg A; Pijnenburg Y; Scheltens P; Barkhof F; Vrenken H
J Alzheimers Dis; 2015; 44(2):635-47. PubMed ID: 25322925
[TBL] [Abstract][Full Text] [Related]
27. Exploring Neural Efficiency in Multiple Sclerosis Patients during the Symbol Digit Modalities Test: A Functional Magnetic Resonance Imaging Study.
Fittipaldi-Márquez MS; Cruz-Gómez ÁJ; Sanchis-Segura C; Belenguer A; Ávila C; Forn C
Neurodegener Dis; 2017; 17(4-5):199-207. PubMed ID: 28538226
[TBL] [Abstract][Full Text] [Related]
28. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
[TBL] [Abstract][Full Text] [Related]
29. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.
Brass SD; Benedict RH; Weinstock-Guttman B; Munschauer F; Bakshi R
Mult Scler; 2006 Aug; 12(4):437-44. PubMed ID: 16900757
[TBL] [Abstract][Full Text] [Related]
30. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
[TBL] [Abstract][Full Text] [Related]
31. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
Kim G; Chu R; Yousuf F; Tauhid S; Stazzone L; Houtchens MK; Stankiewicz JM; Severson C; Kimbrough D; Quintana FJ; Chitnis T; Weiner HL; Healy BC; Bakshi R
Int J Neurosci; 2017 Nov; 127(11):971-980. PubMed ID: 28100092
[TBL] [Abstract][Full Text] [Related]
32. Subcortical atrophy and cognition: sex effects in multiple sclerosis.
Schoonheim MM; Popescu V; Rueda Lopes FC; Wiebenga OT; Vrenken H; Douw L; Polman CH; Geurts JJ; Barkhof F
Neurology; 2012 Oct; 79(17):1754-61. PubMed ID: 23019265
[TBL] [Abstract][Full Text] [Related]
33. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.
Bakshi R; Benedict RH; Bermel RA; Caruthers SD; Puli SR; Tjoa CW; Fabiano AJ; Jacobs L
Arch Neurol; 2002 Jan; 59(1):62-8. PubMed ID: 11790232
[TBL] [Abstract][Full Text] [Related]
34. Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis.
Weier K; Penner IK; Magon S; Amann M; Naegelin Y; Andelova M; Derfuss T; Stippich C; Radue EW; Kappos L; Sprenger T
PLoS One; 2014; 9(1):e86916. PubMed ID: 24466290
[TBL] [Abstract][Full Text] [Related]
35. Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT).
Forn C; Belenguer A; Parcet-Ibars MA; Avila C
J Clin Exp Neuropsychol; 2008 Oct; 30(7):789-96. PubMed ID: 18608672
[TBL] [Abstract][Full Text] [Related]
36. Iron and volume in the deep gray matter: association with cognitive impairment in multiple sclerosis.
Modica CM; Zivadinov R; Dwyer MG; Bergsland N; Weeks AR; Benedict RH
AJNR Am J Neuroradiol; 2015 Jan; 36(1):57-62. PubMed ID: 24948507
[TBL] [Abstract][Full Text] [Related]
37. Is impaired information processing speed a matter of structural or functional damage in MS?
Meijer KA; van Geest Q; Eijlers AJC; Geurts JJG; Schoonheim MM; Hulst HE
Neuroimage Clin; 2018; 20():844-850. PubMed ID: 30278371
[TBL] [Abstract][Full Text] [Related]
38. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
López-Góngora M; Querol L; Escartín A
BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
[TBL] [Abstract][Full Text] [Related]
39. Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
Pontillo G; Cocozza S; Lanzillo R; Russo C; Stasi MD; Paolella C; Vola EA; Criscuolo C; Borrelli P; Palma G; Tedeschi E; Morra VB; Elefante A; Brunetti A
AJNR Am J Neuroradiol; 2019 Jan; 40(1):99-106. PubMed ID: 30573464
[TBL] [Abstract][Full Text] [Related]
40. Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
Gaetano L; Häring DA; Radue EW; Mueller-Lenke N; Thakur A; Tomic D; Kappos L; Sprenger T
Neurology; 2018 Apr; 90(15):e1324-e1332. PubMed ID: 29540589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
